Here's a stronger, more polished version that keeps the dramatic tone while improving the flow and impact:
🎙️ THEO VON: “Was there anyone who seemed almost immune to COVID-19?”
👨⚕️ DR. PETER MCCULLOUGH: “There was one adult group. And honestly, it surprised everyone.”
[Theo leans in, waiting for the answer.]
👨⚕️ MCCULLOUGH: “Smokers.”
😳 THEO VON: “Seriously?”
👨⚕️ MCCULLOUGH: “Yes. In many cases, smokers experienced remarkably mild symptoms, and they were far less likely to develop long COVID. The reason appears to be nicotine.”
🤔 THEO VON: “How does that work?”
👨⚕️ MCCULLOUGH: “Nicotine maintains a constant presence in the bloodstream and appears to interfere with the spike protein's ability to bind effectively. It was one of the most unexpected findings. Frankly, I thought smokers would be among the hardest hit.”
🤔 THEO VON: “So would you recommend nicotine patches?”
👨⚕️ MCCULLOUGH: “For certain individuals suffering from long COVID, it may be worth considering under medical guidance. Nicotine is also classified as a nootropic, meaning it can enhance cognitive function and mental performance. While it is addictive, nicotine itself is distinct from the harmful chemicals found in cigarettes. Nicotine patches, when used appropriately, have a strong safety profile.”
⚠️ One of the most surprising discussions to emerge from the pandemic wasn't about vaccines, masks, or lockdowns.
It was about nicotine.
And almost nobody saw that coming.